February 26, 2024Alimentary Pharmacology & Therapeutics12 citationsOpen Access

Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial

PHPenelope Hey RHRudolf Hoermann MSMarie Sinclair

Key Points

Key points are not available for this paper at this time.

Abstract

Sarcopenia is associated with adverse outcomes in cirrhosis. Branched-chain amino acids (BCAA) target several pathways that lead to muscle loss in this population.

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Hey et al. (2024) studied this question.

synapsesocial.com/papers/68e777acb6db6435876ecb86 https://doi.org/10.1111/apt.17917

Ask AI

Helpful

Bookmark

View Full Paper

February 26, 2024Alimentary Pharmacology & Therapeutics12 citationsOpen Access

Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial

View Full Paper

PHPenelope Hey RHRudolf Hoermann MSMarie Sinclair

Key Points

Key points are not available for this paper at this time.

Abstract

Sarcopenia is associated with adverse outcomes in cirrhosis. Branched-chain amino acids (BCAA) target several pathways that lead to muscle loss in this population.

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Hey et al. (2024) studied this question.

synapsesocial.com/papers/68e777acb6db6435876ecb86 https://doi.org/10.1111/apt.17917

Ask AI

Helpful

Bookmark

View Full Paper